Galecto Inc Stock price
Is Galecto Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Galecto Inc Stock Analysis
Analyst Opinions
10 Analysts have issued a Galecto Inc forecast:
Analyst Opinions
10 Analysts have issued a Galecto Inc forecast:
Don't miss a Thing! We will send you all news about Galecto Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. The company was founded by Ulf Nilsson, Hakon Leffler, Tariq Sethi, and Hans T. Schambye in 2011 and is headquartered in Copenhagen, Denmark.
| Head office | United States |
| CEO | Dr. Schambye |
| Employees | 5 |
| Founded | 2011 |
| Website | galecto.com |


